Most of the patients we see are either approaching total kidney failure or are on dialysis already. We also see patients with type 1 diabetes who are referred for kidney and pancreas transplantation. So most of our patients need a kidney transplant or are pursuing it as a lifestyle change from dialysis, which I don’t think is a really good lifestyle – it’s very inhibiting.
We also see patients with other organ transplants when something along their transplant course has also injured their kidney. We see them until the kidney injury is improved.
The rewarding thing about transplant is the lifestyle change that the patient gets to go through. The patients feel better. They eat better. They have an overall better lifestyle, and that’s what makes it rewarding.
Faculty RankProfessor of Medicine
University of Kentucky, College of Medicine
University of Kentucky
University of Kentucky
Certifications and Special Training
American Board of Internal Medicine
Nephrology, Bone & Mineral MetabolismFourth Floor, Suite 401
UK Good Samaritan Professional Arts Center135 E. Maxwell St.
Lexington KY 40508
Insurance policies can vary widely. Please check with your doctor/clinic for specific insurance information before your visit or procedure to avoid unexpected out-of-pocket costs. See list of insurers
- T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejection.
Drug Des Devel Ther. 2009; 3:205-12. PMID: 19920935. Waid TH, Thompson JS, Siemionow M, Brown SA.
- Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature.
Pharmacotherapy. 2004 Jul; 24(7):932-8. PMID: 15303457. Flynn JD, Akers WS, Jones M, Stevkovic N, Waid T, Mullett T, Jahania S.
- Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.
Am J Kidney Dis. 2003 Feb; 41(2):464-70. PMID: 12552511. Reddy KS, Stablein D, Taranto S, Stratta RJ, Johnston TD, Waid TH, McKeown JW, Lucas BA, Ranjan D.
View all publications on PubMed.
- T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejection. Drug Des Devel Ther. 2009; 3:205-12. PMID: 19920935. Waid TH, Thompson JS, Siemionow M, Brown SA.
- Acute Rejection Treatment
- Continuous Renal Replacement Therapy
- Critical Care Nephrology
- Kidney and Pancreas Transplantation
- Metabolic Bone Disease
- Monoclonal Antibodies
- Renal Failure
Becoming a Living Donor: You Can Help A Family Member or A Stranger